Relapsed Refractory Multiple Myeloma Market Size Expected to Reach US$ 34.4 Billion by 2034
BROOKLYN, NY, USA, February 29, 2024 /EINPresswire.com/ -- Market Overview: The relapsed refractory multiple myeloma market reached a value of US$ 21.0 Billion in 2023 and expected to reach US$ 34.4 Billion by 2034, exhibiting a growth rate (CAGR) of …